1 Oct 2026, 18:49
Substantial Holders—
MSBMESOBLAST LIMITED
Announcement history available from 1 August 2025
Fromto
30 Sept 2026, 18:15
Substantial Holders—
24 Sept 2026, 09:52
Company UpdateMS
23 Sept 2026, 18:41
Substantial Holders—
27 Aug 2026, 08:39
Financial ResultsMS
27 Aug 2026, 08:33
Financial ResultsMS
27 Aug 2026, 08:21
Financial ResultsMS
24 Aug 2026, 17:50
Director Interests—
24 Aug 2026, 17:40
Securities Administration—
24 Aug 2026, 17:38
Presentations—
17 Aug 2026, 10:00
Company UpdateMS
13 Aug 2026, 17:52
Substantial Holders—
7 Aug 2026, 17:02
Substantial Holders—
5 Aug 2026, 18:29
Substantial Holders—
3 Aug 2026, 17:25
Substantial Holders—
31 July 2026, 17:06
Substantial Holders—
30 July 2026, 10:01
Quarterly ReportsMS
24 July 2026, 17:00
Substantial Holders—
22 July 2026, 08:23
Substantial Holders—
21 July 2026, 09:53
Substantial Holders—
21 July 2026, 09:47
Director Interests—
21 July 2026, 09:43
Securities Administration—
21 July 2026, 09:33
Securities Administration—
14 July 2026, 17:31
Securities Administration—
14 July 2026, 17:25
Securities Administration—
14 July 2026, 17:21
Securities Administration—
14 July 2026, 17:15
Securities Administration—
14 July 2026, 17:12
Director Interests—
14 July 2026, 10:00
Company UpdateMS
10 July 2026, 09:57
Periodic ReportsMS
1 July 2026, 09:56
Company Update—
30 June 2026, 08:13
Substantial Holders—
29 June 2026, 08:18
Substantial Holders—
25 June 2026, 09:55
Capital RaisingMS
16 June 2026, 08:18
Substantial Holders—
12 June 2026, 08:23
Substantial Holders—
2 June 2026, 11:51
Presentations—
30 Apr 2026, 09:56
Quarterly ReportsMS
29 Apr 2026, 09:50
Company UpdateMS
16 Apr 2026, 17:22
Director Interests—
16 Apr 2026, 17:13
Securities Administration—
16 Apr 2026, 17:09
Securities Administration—
16 Apr 2026, 17:05
Securities Administration—
16 Apr 2026, 17:03
Securities Administration—
15 Apr 2026, 09:25
Mergers & Acquisitions—
8 Apr 2026, 19:16
Presentations—
8 Apr 2026, 19:08
Presentations—
8 Apr 2026, 12:31
Company Update—
8 Apr 2026, 10:00
Securities Administration—
8 Apr 2026, 09:54
Securities Administration—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 1 Oct 2026, 18:49 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 30 Sept 2026, 18:15 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 24 Sept 2026, 09:52 | FDA Approves New Potency Assay for Commercial Ryoncil | Company Update | MS | 11001 | |
| 23 Sept 2026, 18:41 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 27 Aug 2026, 08:39 | MSB Annual Financial Results and Operational Update | Financial Results | MS | 03003, 14014 | |
| 27 Aug 2026, 08:33 | Annual Financial Results Presentation | Financial Results | MS | 03003, 03026 | |
| 27 Aug 2026, 08:21 | Preliminary Final Report including Appendix 4E | Financial Results | MS | 03003, 03011, 03012, 03013 | |
| 24 Aug 2026, 17:50 | Appendix 3Y - Philip Krause | Director Interests | — | 02009 | |
| 24 Aug 2026, 17:40 | Notification regarding unquoted securities - MSB | Securities Administration | — | 06021 | |
| 24 Aug 2026, 17:38 | Mesoblast 2026 Full Year Financial Results Webcast | Presentations | — | 14014 | |
| 17 Aug 2026, 10:00 | Major Milestone Treatment Completed in P3 Trial for CLBP | Company Update | MS | 11001 | |
| 13 Aug 2026, 17:52 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 7 Aug 2026, 17:02 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 5 Aug 2026, 18:29 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 3 Aug 2026, 17:25 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 31 July 2026, 17:06 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 30 July 2026, 10:01 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 24 July 2026, 17:00 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 22 July 2026, 08:23 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 21 July 2026, 09:53 | Mesoblast CEO Makes Investment to Increase Share Ownership | Substantial Holders | — | 02006, 06009 | |
| 21 July 2026, 09:47 | Appendix 3Y - Silviu Itescu | Director Interests | — | 02009 | |
| 21 July 2026, 09:43 | Notification regarding unquoted securities - MSB | Securities Administration | — | 06021 | |
| 21 July 2026, 09:33 | Application for quotation of securities - MSB | Securities Administration | — | 06020 | |
| 14 July 2026, 17:31 | Notification of cessation of securities - MSB | Securities Administration | — | 06027 | |
| 14 July 2026, 17:25 | Notification regarding unquoted securities - MSB | Securities Administration | — | 06021 | |
| 14 July 2026, 17:21 | Application for quotation of securities - MSB | Securities Administration | — | 06020 | |
| 14 July 2026, 17:15 | Notification regarding unquoted securities - MSB | Securities Administration | — | 06021 | |
| 14 July 2026, 17:12 | Appendix 3Y - Silviu Itescu | Director Interests | — | 02009 | |
| 14 July 2026, 10:00 | Pivotal Phase 3 Trial in CLBP Achieves 300 Treated Patients | Company Update | MS | 11001 | |
| 10 July 2026, 09:57 | Ryoncil Q4 Net Revenue of US$36M and US$115M for Full Year | Periodic Reports | MS | 03014 | |
| 1 July 2026, 09:56 | Receives FDA BLA Filing Number and Requests Modular Review | Company Update | — | 11001 | |
| 30 June 2026, 08:13 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 29 June 2026, 08:18 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 25 June 2026, 09:55 | Mesoblast Draws US$50M from Five-Year Non-Dilutive Facility | Capital Raising | MS | 03022 | |
| 16 June 2026, 08:18 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 12 June 2026, 08:23 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 2 June 2026, 11:51 | ASX CEO Connect Presentation | Presentations | — | 03026 | |
| 30 Apr 2026, 09:56 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 29 Apr 2026, 09:50 | Patient Recruitment Target Achieved in CLBP Pivotal Trial | Company Update | MS | 11001 | |
| 16 Apr 2026, 17:22 | Appendix 3Y for Gregory George | Director Interests | — | 02009 | |
| 16 Apr 2026, 17:13 | Notification of cessation of securities - MSB | Securities Administration | — | 06027 | |
| 16 Apr 2026, 17:09 | Notification regarding unquoted securities - MSB | Securities Administration | — | 06021 | |
| 16 Apr 2026, 17:05 | Application for quotation of securities - MSB | Securities Administration | — | 06020 | |
| 16 Apr 2026, 17:03 | Notification regarding unquoted securities - MSB | Securities Administration | — | 06021 | |
| 15 Apr 2026, 09:25 | Acquires CAR Platform for Precision-Enhanced Cell Products | Mergers & Acquisitions | — | 07001 | |
| 8 Apr 2026, 19:16 | Mesoblast R&D Day Presentation | Presentations | — | 03026 | |
| 8 Apr 2026, 19:08 | Mesoblast R&D Day Features Commercial & Blockbuster Programs | Presentations | — | 12008, 14014 | |
| 8 Apr 2026, 12:31 | FDA Clears Ryoncil IND for Registration Trial in DMD | Company Update | — | 11001 | |
| 8 Apr 2026, 10:00 | Application for quotation of securities - MSB | Securities Administration | — | 06020 | |
| 8 Apr 2026, 09:54 | Cleansing Notice | Securities Administration | — | 06018 |
1–50 of 134
1 / 3